Wird geladen...
Initial Testing of VS-4718, a novel inhibitor of Focal Adhesion Kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program
VS-4718 was tested against the PPTP’s in vitro cell line panel and showed a median relative IC(50) of 1.22 µM. VS-4718 was tested in vivo against the PPTP xenograft models using a dose of 50 mg/kg administered by the oral route twice daily for 21 days. VS-4718 induced significant differences in EFS...
Gespeichert in:
| Veröffentlicht in: | Pediatr Blood Cancer |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5578428/ https://ncbi.nlm.nih.gov/pubmed/27786412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.26304 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|